Fabian Gerlinghaus from Cellares explains how automation, closed systems, and global manufacturing networks could transform cell therapy from a niche treatment to a widely accessible medicine.
Source: The Scientist Atom Feed
You might be interested in …
Digital heart twins can guide a lifesaving procedure
The “digital twins” helped doctors spot good targets for heart ablation in 10 patients. Months later, all of them are free of sustained faulty rhythms.
FY2027 Budget Request Slashes Billions in Science Funding
The Trump administration is requesting the cancellation of billions of dollars in funds for space science, renewable energy, carbon removal, and climate change education in its FY 2027 budget.
At least half of U.S. teens use chatbots for homework and more
Most also feel optimistic about benefits of chatbots and other AI. But use of this tech varies quite a bit by race and family income.
